DRLAX | MGLMX | DRLAX / MGLMX | |
Total Expense Ratio | 1.30 | 0.94 | 138% |
Annual Report Gross Expense Ratio | 1.77 | 0.95 | 186% |
Fund Existence | 19 years | 11 years | - |
Gain YTD | 7.776 | 3.425 | 227% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 309M | 2.21B | 14% |
Annual Yield % from dividends | 2.25 | 2.47 | 91% |
Returns for 1 year | 1.29 | -4.91 | -26% |
Returns for 3 years | 9.40 | 0.32 | 2,935% |
Returns for 5 years | 18.18 | 8.44 | 215% |
Returns for 10 years | 24.56 | 32.69 | 75% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LAVGX | 16.45 | 0.11 | +0.67% |
Lord Abbett International Growth R6 | |||
HFSIX | 16.18 | 0.06 | +0.37% |
Hartford Schroders Intl Cntrrn Val I | |||
JIEZX | 22.08 | 0.07 | +0.32% |
JPMorgan International Equity R2 | |||
MXMDX | 22.15 | 0.06 | +0.25% |
Empower S&P Mid Cap 400® Index Inv | |||
FCNIX | 55.08 | 0.13 | +0.24% |
Fidelity Advisor Consumer Discret I |